These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9400898)
1. New therapies in sepsis. Vincent JL Chest; 1997 Dec; 112(6 Suppl):330S-338S. PubMed ID: 9400898 [No Abstract] [Full Text] [Related]
2. Treatment of septic shock with immunotherapy. Smith AL Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107 [TBL] [Abstract][Full Text] [Related]
3. Current status of clinical trials with anti-TNF. Porter SB Chest; 1997 Dec; 112(6 Suppl):339S-341S. PubMed ID: 9400899 [No Abstract] [Full Text] [Related]
4. [Problems and perspective approaches to correction of mediator response in sepsis]. Mironov PI; Rudnov VA Anesteziol Reanimatol; 1999; (3):54-9. PubMed ID: 10458039 [No Abstract] [Full Text] [Related]
5. Immunological therapy of sepsis: experimental therapies. Arndt P; Abraham E Intensive Care Med; 2001; 27 Suppl 1():S104-15. PubMed ID: 11307366 [No Abstract] [Full Text] [Related]
6. Emerging therapies for sepsis and septic shock. Oh HM Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353 [TBL] [Abstract][Full Text] [Related]
7. Search for effective immunomodulating strategies against sepsis. Vincent JL Lancet; 1998 Mar; 351(9107):922-3. PubMed ID: 9734931 [No Abstract] [Full Text] [Related]
8. Therapies for sepsis. Emerging therapies for sepsis and septic shock. Abraham E West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195 [No Abstract] [Full Text] [Related]
9. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Balk RA Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467 [TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy in sepsis syndrome]. Schellekens JF; van Deventer SJ Ned Tijdschr Geneeskd; 1992 May; 136(22):1050-4. PubMed ID: 1603159 [No Abstract] [Full Text] [Related]
11. The problems and challenges of immunotherapy in sepsis. Nasraway SA Chest; 2003 May; 123(5 Suppl):451S-9S. PubMed ID: 12740228 [TBL] [Abstract][Full Text] [Related]
12. What's new in Shock? September 2014. Banerjee A Shock; 2014 Sep; 42(3):177-8. PubMed ID: 25122081 [No Abstract] [Full Text] [Related]
13. New strategies in nonantibiotic treatment of gram-negative sepsis. Cohn J; Bone RC Cleve Clin J Med; 1992; 59(6):608-15. PubMed ID: 1424072 [TBL] [Abstract][Full Text] [Related]
14. Potential strategies for inflammatory mediator manipulation: retrospect and prospect. Fisher CJ; Zheng Y World J Surg; 1996 May; 20(4):447-53. PubMed ID: 8662133 [TBL] [Abstract][Full Text] [Related]
15. Targets for sepsis therapies: tumor necrosis factor versus interleukin-1. Russell DA; Thompson RC Curr Opin Biotechnol; 1993 Dec; 4(6):714-21. PubMed ID: 7764470 [TBL] [Abstract][Full Text] [Related]
17. Management of Sepsis and Septic Shock for the Obstetrician-Gynecologist. Plante LA Obstet Gynecol Clin North Am; 2016 Dec; 43(4):659-678. PubMed ID: 27816153 [TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy of sepsis and septic shock]. Ivanović D; Gjurasin M; Gasparović V; Radonić R; Kvarantan M; Merkler M Lijec Vjesn; 1995 Jun; 117 Suppl 2():8-11. PubMed ID: 8649167 [TBL] [Abstract][Full Text] [Related]
19. Clinical sepsis trials. Abraham E Chest; 1994 Mar; 105(3 Suppl):53S-55S. PubMed ID: 8131613 [No Abstract] [Full Text] [Related]
20. Sepsis pathophysiology and anesthetic consideration. Yuki K; Murakami N Cardiovasc Hematol Disord Drug Targets; 2015; 15(1):57-69. PubMed ID: 25567335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]